Directed evolution of and structural insights into antibody-mediated disruption of a stable receptor-ligand complex
Facilitated dissociation is a mechanism where antibody-mediated disruption of high-affinity complexes can enhance the therapeutic effects of a drug. Here the authors present a yeast display approach to select and engineer omalizumab variants that dissociate receptor-bound IgE to accelerate its inhib...
Guardado en:
Autores principales: | Luke F. Pennington, Pascal Gasser, Silke Kleinboelting, Chensong Zhang, Georgios Skiniotis, Alexander Eggel, Theodore S. Jardetzky |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ce93054282b0409585dfb3dd0b17d1d1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The mechanistic and functional profile of the therapeutic anti-IgE antibody ligelizumab differs from omalizumab
por: Pascal Gasser, et al.
Publicado: (2020) -
Structural basis of omalizumab therapy and omalizumab-mediated IgE exchange
por: Luke F. Pennington, et al.
Publicado: (2016) -
Cryptocurrency as disruptive technology: theoretical insights
por: Tadas Limba, et al.
Publicado: (2019) -
Disruptive mood dysregulation disorder: current insights
por: Baweja R, et al.
Publicado: (2016) -
Electrochemically-stable ligands bridge the photoluminescence-electroluminescence gap of quantum dots
por: Chaodan Pu, et al.
Publicado: (2020)